Stander Use in Spinal Muscular Atrophy: Results From a Large Natural History Database

被引:8
作者
Townsend, Elise L. [1 ,2 ,3 ]
Simeone, Sarah D. [2 ,3 ]
Krosschell, Kristin J. [4 ,5 ]
Zhang, Ren Zhe [2 ,3 ]
Swoboda, Kathryn J. [2 ,3 ]
机构
[1] MGH Inst Hlth Profess, Sch Hlth & Rehabil Sci, Dept Phys Therapy, 36 1st Ave, Boston, MA 02129 USA
[2] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[4] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA
[5] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA
关键词
adverse events; Functional Motor Scale Extend; intervention; Modified Hammersmith Functional Motor Scale-Extend; motor performance; respiratory support; spinal muscular atrophy; stander use; supported standing; Test of Infant Motor Performance Screening Items; weight bearing; FUNCTIONAL MOTOR SCALE; SHAM CONTROL; MANAGEMENT; NUSINERSEN; DIAGNOSIS; RECOMMENDATIONS; RELIABILITY; CARE;
D O I
10.1097/PEP.0000000000000713
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Purpose: The purpose of this study was to describe stander use in a natural history cohort of drug therapy-naive children with spinal muscular atrophy (SMA) who are not walking and identify factors associated with consistent stander use. Methods: Data from 397 children with SMA types 1 and 2 characterized the prevalence and frequency of stander use. Predictors of consistent stander use explored were SMA type, survival motor neuron 2 gene (SMN2) copy number, respiratory support, and motor performance. Results: Prevalence of consistent stander use was 13% in type 1 and 68% in type 2. SMA type,SMN2copy number, respiratory support, and head rotation control each predicted consistent stander use. Conclusions: Findings characterize stander use in children with SMA who are not walking, address important safety considerations, identify factors that may inform physical therapists' clinical decision-making related to standing program prescription, and provide guidance for future prospective studies.
引用
收藏
页码:235 / 241
页数:7
相关论文
共 30 条
  • [1] Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy
    Al-Zaidy, Samiah
    Pickard, A. Simon
    Kotha, Kavitha
    Alfano, Lindsay N.
    Lowes, Linda
    Paul, Grace
    Church, Kathleen
    Lehman, Kelly
    Sproule, Douglas M.
    Dabbous, Omar
    Maru, Benit
    Berry, Katherine
    Arnold, W. David
    Kissel, John T.
    Mendell, Jerry R.
    Shell, Richard
    [J]. PEDIATRIC PULMONOLOGY, 2019, 54 (02) : 179 - 185
  • [2] SPINAL MUSCULAR ATROPHY: DIAGNOSIS AND MANAGEMENT IN A NEW THERAPEUTIC ERA
    Arnold, W. David
    Kassar, Darine
    Kissel, John T.
    [J]. MUSCLE & NERVE, 2015, 51 (02) : 157 - 167
  • [3] RESNA Position on the Application of Wheelchair Standing Devices
    Arva, Julianna
    Paleg, Ginny
    Lange, Michelle
    Lieberman, Jenny
    Schmeler, Mark
    Dicianno, Brad
    Babinec, Mike
    Rosen, Lauren
    [J]. ASSISTIVE TECHNOLOGY, 2009, 21 (03) : 161 - 168
  • [4] Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases
    Butchbach, Matthew E. R.
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2016, 3
  • [5] Nusinersen for the treatment of spinal muscular atrophy
    Chiriboga, Claudia A.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (10) : 955 - 962
  • [6] Prevention of Drowning
    Denny, Sarah A.
    Quan, Linda
    Gilchrist, Julie
    McCallin, Tracy
    Shenoi, Rohit
    Yusuf, Shabana
    Hoffman, Benjamin
    Weiss, Jeffrey
    Agran, Phyllis F.
    Denny, Sarah A.
    Hirsh, Michael
    Johnston, Brian
    Lee, Lois K.
    Monroe, Kathy
    Schaechter, Judy
    Tenenbein, Milton
    Zonfrillo, Mark R.
    Quinlan, Kyran
    [J]. PEDIATRICS, 2019, 143 (05)
  • [7] Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
    Finkel, R. S.
    Mercuri, E.
    Darras, B. T.
    Connolly, A. M.
    Kuntz, N. L.
    Kirschner, J.
    Chiriboga, C. A.
    Saito, K.
    Servais, L.
    Tizzano, E.
    Topaloglu, H.
    Tulinius, M.
    Montes, J.
    Glanzman, A. M.
    Bishop, K.
    Zhong, Z. J.
    Gheuens, S.
    Bennett, C. F.
    Schneider, E.
    Farwell, W.
    De Vivo, D. C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (18) : 1723 - 1732
  • [8] Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics
    Finkel, Richard S.
    Mercuri, Eugenio
    Meyer, Oscar H.
    Simonds, Anita K.
    Schroth, Mary K.
    Graham, Robert J.
    Kirschner, Janbernd
    Iannaccone, Susan T.
    Crawford, Thomas O.
    Woods, Simon
    Muntoni, Francesco
    Wirth, Brunhilde
    Montes, Jacqueline
    Main, Marion
    Mazzone, Elena S.
    Vitale, Michael
    Snyder, Brian
    Quijano-Roy, Susana
    Bertini, Enrico
    Davis, Rebecca Hurst
    Qian, Ying
    Sejersen, Thomas
    [J]. NEUROMUSCULAR DISORDERS, 2018, 28 (03) : 197 - 207
  • [9] Fujak Albert, 2005, Ortop Traumatol Rehabil, V7, P175
  • [10] Fujak Albert, 2010, Ortop Traumatol Rehabil, V12, P410